GV 2017 GP, L.L.C.

GV 2017 GP, L.L.C. has an estimated net worth of $166 Million. This is based on reported shares across multiple companies, which include Arcus Biosciences, Inc., Gitlab Inc., Verve Therapeutics, Inc., Ethos Technologies Inc., and Decibel Therapeutics, Inc..

2021 was GV 2017 GP, L.L.C.'s most active year for acquiring shares with 3 total transactions. GV 2017 GP, L.L.C.'s most active month to acquire stocks was the month of December. 2022 was GV 2017 GP, L.L.C.'s most active year for disposing of shares, totalling 37 transactions. GV 2017 GP, L.L.C.'s most active month to dispose stocks was the month of October. 2021 saw GV 2017 GP, L.L.C. paying a total of $0.00 for 15,704,330 shares, this is the most they've acquired in one year. In 2026 GV 2017 GP, L.L.C. cashed out on 7,437,150 shares for a total of $35,060,852.00, their largest year based on trade value.